摘要
目的：观察糖尿病患者行白内障超声乳化吸出联合人工晶体植入术的临床效果。方法：５６例（８１只眼）糖尿病患者接受白内障超声乳化吸出联合人工晶体植入术，连续随机抽取年龄相当的非糖尿病患者５６例（８７只眼）作对照组。两组白内障超声乳化吸出联合人工晶体植入手术方法相同，植入光学部直径５．５毫米ＰＭＭＡ人工晶体。结果：糖尿病患者的８１只眼中，术后矫正视力≥０．５者共６３只眼（７８％），非糖尿病患者的８７只眼中，术后矫正视力≥０．５者为７６只眼（８７％）。两组经统计学处理，差异无显著性（Ｐ＞０．０５）。两组在术后并发症方面，差异亦无显著性（Ｐ＞０．０５）。但糖尿病患者中，术前瞳孔不能充分散大或术中瞳孔缩小的病例明显多于非糖尿病者，经统计学处理有显著性差异（Ｐ＜０．０５）。结论：糖尿病患者行白内障超声乳化吸出联合人工晶体植入术，可明显改善视力，在术后视力和手术并发症方面与一般患者无明显差异。说明超声乳化吸出术治疗糖尿病患者白内障是安全有效的，增殖性糖尿病视网膜病变和黄斑病变是影响术后视力的主要因素。小直径的人工晶体不影响术后眼底观察。
To investigate clinical results of phacoemulsification combined with intraocular lens implantation in diabetics.There were two groups of patients,including 56 diabetics with or without diabetic retinopathy and 56 nondiabetics.Two groups were treated with phacoemulsification combined with intraocular lens implantation.The post operative corrected visual acuities of 0 5 or better were achieved in 63 of 81(78%) diabetic eyes and in 76 of 87(87%) nondiabetic eyes. The comparision between the two groups showed that there was no significant difference in intra operative or post operative complications(P>0 05) Our results demonstrated that phacoemulsification in diabetics was safe and effective.The major cause of poor visual acuity in the diabetic group was maculopathy and proliferative diabetic retinopathy.The use of a small intraocular lens did not prevent adequate fundal examination or photocoagulation.
出处
《眼科》
CAS
1998年第2期67-69,共3页
Ophthalmology in China
